Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Cytochrome P450 proteins are involved in metabolism of drugs and xenobiotics. In the endoplasmic reticulum a single nicotinamide adenine dinucleotide phosphate (NADPH) P450 oxidoreductase (POR) supplies electrons to all microsomal P450s for catalytic activity. POR is a flavoprotein that contains both flavin mononucleotide and flavin adenine dinucleotide as cofactors and uses NADPH as the source of electrons. We have recently reported a number of POR mutations in the patients with disordered steroidogenesis. In the first report we had described missense mutations (A287P, R457H, V492E, C569Y, and V608F) identified in four patients with defects in steroid production. Each POR variant was produced as recombinant N‐27 form of the enzyme in bacteria and as full‐length form in yeast. Membranes from bacteria or yeast expressing normal or variant POR were purified and their activities were characterized in cytochrome c and CYP17A1 assays. Later we have published a larger study that described a whole range of POR mutations and characterized the mutants/polymorphisms A115V, T142A, M263V, Y459H, A503V, G539R, L565P, R616X, V631I, and F646del from the sequencing of patient DNA. We also studied POR variants Y181D, P228L, R316W, G413S, and G504R that were available in public databases or published literature. Three‐dimensional structure of rat POR is known and we have used this structure to deduce the structure–function correlation of POR mutations in human. The missense mutations found in patients with disordered steroidogenesis are generally in the co‐factor binding and functionally important domains of POR and the apparent polymorphisms are found in regions with lesser structural importance. A variation in POR can alter the activity of all microsomal P450s, and therefore, can affect the metabolism of drugs and xenobiotics even when the P450s involved are otherwise normal. It is important to study the genetic and biochemical basis of POR variants in human population to gain information about possible differences in P450 mediated reactions among the individuals carrying a variant or polymorphic form of POR that could impact their metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, M., Roberts, D. L., Paschke, R., Shea, T. M., Masters, B. S. S., & Kim, J.-J. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8411 · Cited by 744
Structure and function of cytochromes P450: a comparative analysis of three crystal structures
Hasemann, C. A., Kurumbail, R. G., Boddupalli, S. S., Peterson, J. A., & Deisenhofer, J. (1995) · Structure · doi:10.1016/s0969-2126(01)00134-4 · Cited by 692
Karplus, P. A., Daniels, M. J., & Herriott, J. R. (1991) · Science · doi:10.1126/science.1986412 · Cited by 536
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509
Self-citationZhang, L. H., Rodriguez, H., Ohno, S., & Miller, W. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10619 · Cited by 455
Arlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345
Huang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429417 · Cited by 336
Self-citationHenderson, C. J., Otto, D. M. E., Carrie, D., Magnuson, M. A., McLaren, A. W., Rosewell, I., & Wolf, C. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212087200 · Cited by 258
Shen, A. L., O'Leary, K. A., & Kasper, C. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111408200 · Cited by 225
Liver-specific Deletion of the NADPH-Cytochrome P450 Reductase Gene
Gu, J., Weng, Y., Zhang, Q.-Y., Cui, H., Behr, M., Wu, L., Yang, W., Zhang, L., & Ding, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303125200 · Cited by 214
Research works printed but not linked: 52
- 10.1111/j.1469-1809.1989.tb01798.x · DOI · Paper page
- Horecker B.L., 1949, The reduction of cytochrome c by xanthine oxidase, J. Biol. Chem., 178, 683, 10.1016/S0021-9258(18)56885-X · DOI
- Horecker B.L., 1950, Triphosphopyridine nucleotide‐cytochrome c reductase in liver, J. Biol. Chem., 183, 593, 10.1016/S0021-9258(19)51185-1 · DOI · Paper page
- 10.1016/S0021-9258(18)93967-0 · DOI · Paper page
- 10.1016/S0021-9258(19)73803-4 · DOI · Paper page
- Lu A.Y., 1969, Resolution of the cytochrome P‐450‐containing ω‐hydroxylation system of liver microsomes into three components, J. Biol. Chem., 244, 3714, 10.1016/S0021-9258(18)83427-5 · DOI · Paper page
- 10.1016/0003-9861(76)90099-0 · DOI
- 10.1016/0014-5793(83)80198-7 · DOI
- 10.1016/j.abb.2005.06.019 · DOI
- 10.1016/S0021-9258(19)86797-2 · DOI · Paper page
- 10.1016/S0021-9258(19)45183-1 · DOI · Paper page
- 10.1016/0304-4165(72)90259-0 · DOI
- 10.1006/abbi.1999.1602 · DOI
- 10.1124/jpet.104.073353 · DOI
- 10.1081/ERC-200044134 · DOI · Paper page
- 10.1002/ajmg.a.31112 · DOI
- 10.1158/0008-5472.CAN-06-4801 · DOI
- 10.1016/S0163-7258(03)00031-7 · DOI
- 10.1046/j.1432-1033.2003.03633.x · DOI · Paper page
- 10.1021/bi00736a018 · DOI · Paper page
- 10.1021/bi001718u · DOI · Paper page
- 10.1074/jbc.M101731200 · DOI · Paper page
- 10.1074/jbc.M212309200 · DOI · Paper page
- 10.1021/bi972458s · DOI · Paper page
- 10.1016/0378-4274(95)03522-2 · DOI
- 10.1016/S0076-6879(96)72008-6 · DOI · Paper page
- Urban P., 1993, Xenobiotic metabolism in humanized yeast: engineered yeast cells producing human NADPH‐cytochrome P‐450 reductase, cytochrome b5, epoxide hydrolase and P‐450s, Biochem. Soc. Trans., 21, 1028, 10.1042/bst0211028 · DOI
- 10.1074/jbc.273.6.3158 · DOI · Paper page
- 10.1124/dmd.106.011056 · DOI
- 10.1016/S0300-9084(97)82531-X · DOI
- 10.1021/bi9719399 · DOI · Paper page
- 10.1016/0003-9861(88)90358-X · DOI
- 10.1074/jbc.270.46.27475 · DOI · Paper page
- 10.1016/0003-9861(91)90542-Q · DOI
- 10.1006/abbi.1993.1347 · DOI
- 10.1016/0003-9861(92)90140-R · DOI
- Shimizu T., 1991, Probing the role of lysines and arginines in the catalytic function of cytochrome P450d by site‐directed mutagenesis. Interaction with NADPH‐cytochrome P450 reductase, J. Biol. Chem., 266, 3372, 10.1016/S0021-9258(19)67801-4 · DOI · Paper page
- Nisimoto Y., 1986, Localization of cytochrome c‐binding domain on NADPH‐cytochrome P‐450 reductase, J. Biol. Chem., 261, 14232, 10.1016/S0021-9258(18)67009-7 · DOI · Paper page
- 10.1006/abbi.1996.0395 · DOI
- 10.1016/S0076-6879(96)72004-9 · DOI
- 10.1021/bi992936u · DOI · Paper page
- 10.3109/03602538909103558 · DOI · Paper page
- 10.1111/j.1432-1033.1989.tb14671.x · DOI · Paper page
- 10.1038/351714a0 · DOI · Paper page
- 10.1016/S0021-9258(18)83274-4 · DOI · Paper page
- 10.1074/jbc.M008380200 · DOI · Paper page
- 10.1021/bi960587n · DOI
- 10.1074/jbc.274.9.5391 · DOI · Paper page
- 10.1038/343038a0 · DOI · Paper page
- 10.1021/bi00447a054 · DOI · Paper page
- 10.1016/S0021-9258(18)54879-1 · DOI · Paper page
- Haniu M., 1984, Structural analysis of NADPH‐cytochrome P‐450 reductase from porcine hepatic microsomes. Sequences of proteolytic fragments, cysteine‐containing peptides, and a NADPH‐protected cysteine peptide, J. Biol. Chem., 259, 13703, 10.1016/S0021-9258(18)89802-7 · DOI · Paper page
Cited by
NADPH P450 oxidoreductase: Structure, function, and pathology of diseases
Pandey, A. V., & Flück, C. E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.010 · Cited by 279
Self-citationModulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
Pandey, A. V., Kempná, P., Hofer, G., Mullis, P. E., & Flück, C. E. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0245 · Cited by 132
Self-citationPharmacogenomics of human P450 oxidoreductase
Pandey, A. V., & Sproll, P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00103 · Cited by 92
“Disruption of POR affects all microsomal P450 enzyme activities (Flück et al., 2007; Pandey and Flück, 2013).”
BackgroundInfluentialSelf-citationP450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms
Burkhard, F. Z., Parween, S., Udhane, S. S., Flück, C. E., & Pandey, A. V. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.04.003 · Cited by 79
Self-citationFlück, C. E., Mullis, P. E., & Pandey, A. V. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.035 · Cited by 59
Self-citation
Metadata
- Authors
- Flück, C. E., Nicolo, C., & Pandey, A. V.
- Venue
- Fundamental & Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2007-07-18
- Volume
- 21
- Issue
- 4
- Pages
- 399-410
- ISSN
- 0767-3981 (ISSN-L)
- 1472-8206
- OpenAlex
- W2087610174
- Cited by
- 55
- References
- 26
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase. https://app.cochat.ai/papers/10.1111/j.1472-8206.2007.00520.x
- The paper
- Flück, C. E., Nicolo, C., & Pandey, A. V. (2007). Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/j.1472-8206.2007.00520.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.